Cargando…

XRCC1 Is a Promising Predictive Biomarker and Facilitates Chemo-Resistance in Gallbladder Cancer

Gallbladder cancer is a relatively uncommon human malignant tumor with an extremely poor prognosis. Currently, no biomarkers can accurately diagnose gallbladder cancer and predict patients’ prognosis. XRCC1 is involved in tumorigenesis, progression, and chemo-resistance of several human cancers, but...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wu, Zhengchun, Miao, Xiongying, Zhang, Yuanfang, Li, Daiqiang, Zou, Qiong, Yuan, Yuan, Liu, Rushi, Yang, Zhulin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Molecular Biosciences
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7212355/ https://www.ncbi.nlm.nih.gov/pubmed/32426369 http://dx.doi.org/10.3389/fmolb.2020.00070

Ejemplares similares

Prognostic and Clinicopathological Significance of X-Box-Binding Protein 1 and N-Acetyltransferase 1 in Gallbladder Cancer
por: Liu, Rushi, et al.
Publicado: (2020)

Prognostic and clinicopathological significance of Hapto and Gremlin1 expression in extrahepatic cholangiocarcinoma
por: Wu, Zhengchun, et al.
Publicado: (2020)

Prognostic and Clinicopathological Significance of EphB3 and Dysadherin Expression in Extrahepatic Cholangiocarcinoma
por: Wu, Zhengchun, et al.
Publicado: (2020)

Expression of UGP2 and CFL1 expression levels in benign and malignant pancreatic lesions and their clinicopathological significance
por: Wang, Lingxiang, et al.
Publicado: (2018)

Association of Mental Health-Related Proteins DAXX, DRD3, and DISC1 With the Progression and Prognosis of Chondrosarcoma
por: He, Lile, et al.
Publicado: (2019)

The Clinical and Pathological Significance of Nectin-2 and DDX3 Expression in Pancreatic Ductal Adenocarcinomas
por: Liang, Shan, et al.
Publicado: (2015)

Circular RNAs Are Promising Biomarkers in Liquid Biopsy for the Diagnosis of Non-small Cell Lung Cancer
por: Huang, Lanxiang, et al.
Publicado: (2021)

Cytoskeleton-Associated Protein 4, a Promising Biomarker for Tumor Diagnosis and Therapy
por: Li, Shuang-Xi, et al.
Publicado: (2021)

Expression levels of HMGA2 and CD9 and its clinicopathological significances in the benign and malignant lesions of the gallbladder
por: Zou, Qiong, et al.
Publicado: (2012)

PIWI-Interacting RNAs (piRNAs): Promising Applications as Emerging Biomarkers for Digestive System Cancer
por: Cai, Aiting, et al.
Publicado: (2022)

TRPM4 and TRPV2 are two novel prognostic biomarkers and promising targeted therapy in UVM
por: Wang, Jiong, et al.
Publicado: (2022)

Cancer-testis antigen CEP55 serves as a prognostic biomarker and is correlated with immune infiltration and immunotherapy efficacy in pan-cancer
por: Xie, Xiaodong, et al.
Publicado: (2023)

Expression of FOXP1 and FOXO3a in extrahepatic cholangiocarcinoma and the implications in clinicopathological significance and prognosis
por: He, Jun, et al.
Publicado: (2019)

Increased expression of cystathionine beta-synthase and chemokine ligand 21 is closely associated with poor prognosis in extrahepatic cholangiocarcinoma
por: Wang, Lingxiang, et al.
Publicado: (2020)

Immune-related gene-based model predicts the survival of colorectal carcinoma and reflected various biological statuses
por: Kang, Zhengchun, et al.
Publicado: (2023)

Zic Family Member 2 (ZIC2): a Potential Diagnostic and Prognostic Biomarker for Pan-Cancer
por: Lv, Zhengtong, et al.
Publicado: (2021)

TSG101 and PEG10 are prognostic markers in squamous cell/adenosquamous carcinomas and adenocarcinoma of the gallbladder
por: LIU, ZIRU, et al.
Publicado: (2014)

MCM2 and TIP30 are prognostic markers in squamous cell/adenosquamous carcinoma and adenocarcinoma of the gallbladder
por: Liu, Ziru, et al.
Publicado: (2016)

APEX1 predicts poor prognosis of gallbladder cancer and affects biological properties of CD133(+) GBC-SD cells via upregulating Jagged1
por: Wu, Zhengchun, et al.
Publicado: (2023)

Deoxythymidylate Kinase as a Promising Marker for Predicting Prognosis and Immune Cell Infiltration of Pan-cancer
por: Lan, Tianfeng, et al.
Publicado: (2022)

Family 1 glycosyltransferases (GT1, UGTs) are subject to dilution-induced inactivation and low chemo stability toward their own acceptor substrates
por: Teze, David, et al.
Publicado: (2022)

Negative Expression of DSG1 and DSG2, as Prognostic Biomarkers, Impacts on the Overall Survival in Patients with Extrahepatic Cholangiocarcinoma
por: Xu, Shu, et al.
Publicado: (2020)

Potential Role of NEU1 in Hepatocellular Carcinoma: A Study Based on Comprehensive Bioinformatical Analysis
por: Wu, Zhulin, et al.
Publicado: (2021)

Plant-derived extracts and metabolic modulation in leukemia: a promising approach to overcome treatment resistance
por: Arévalo, Cindy Mayerli, et al.
Publicado: (2023)

Characterization of the Prognostic Values of the CXCR1-7 in Clear Cell Renal Cell Carcinoma (ccRCC) Microenvironment
por: Wu, Zhulin, et al.
Publicado: (2020)

LBX2-AS1 as a Novel Diagnostic Biomarker and Therapeutic Target Facilitates Multiple Myeloma Progression by Enhancing mRNA Stability of LBX2
por: Jia, Haipeng, et al.
Publicado: (2021)

Over-Expression and Prognostic Significance of FATP5, as a New Biomarker, in Colorectal Carcinoma
por: Geng, Qi-Shun, et al.
Publicado: (2022)

Editorial: Multiplex Immunohistochemistry/Immunofluorescence Technique: The Potential and Promise for Clinical Application
por: Fincham, Rachel Elizabeth Ann, et al.
Publicado: (2022)

Mastoparans: A Group of Multifunctional α-Helical Peptides With Promising Therapeutic Properties
por: de Santana, Carlos José Correia, et al.
Publicado: (2022)

lncRNAs-EZH2 interaction as promising therapeutic target in cutaneous melanoma
por: Wozniak, Michal, et al.
Publicado: (2023)

A promising nucleic acid therapy drug: DNAzymes and its delivery system
por: Xiao, Lang, et al.
Publicado: (2023)

Mechanotransductive receptor Piezo1 as a promising target in the treatment of fibrosis diseases
por: Xu, Yi, et al.
Publicado: (2023)

Metabolomics: a promising tool for deciphering metabolic impairment in heavy metal toxicities
por: Akash, Muhammad Sajid Hamid, et al.
Publicado: (2023)

Transcriptomic Analysis Identifies Complement Component 3 as a Potential Predictive Biomarker for Chemotherapy Resistance in Colorectal Cancer
por: He, Xiao-Shun, et al.
Publicado: (2021)

Prognostic Effect of Microenvironment Phenotype in Triple-Negative Breast Cancer: Biomarker Analysis of a Prospective Trial
por: Zhu, Si-Yuan, et al.
Publicado: (2021)

Nanoparticles in association with antimicrobial peptides (NanoAMPs) as a promising combination for agriculture development
por: Maximiano, Mariana Rocha, et al.
Publicado: (2022)

Gene Architecture Facilitates Intron-Mediated Enhancement of Transcription
por: Dwyer, Katherine, et al.
Publicado: (2021)

Multi-omics analysis of LAMB3 as a potential immunological and biomarker in pan-cancer
por: Wang, Yanghao, et al.
Publicado: (2023)

Association of BDNF and BMPR1A with clinicopathologic parameters in benign and malignant gallbladder lesions
por: Xiong, Li, et al.
Publicado: (2013)

Post-Translational Modification of GPX4 is a Promising Target for Treating Ferroptosis-Related Diseases
por: Cui, Can, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_r1irttir73rhr2agu63r0kpe9u